AVIARQ Trademark

Trademark Overview

On Friday, February 17, 2006, a trademark application was filed for AVIARQ with the United States Patent and Trademark Office. The USPTO has given the AVIARQ trademark a serial number of 78817912. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, July 26, 2006. This trademark is owned by Pfizer Inc.. The AVIARQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pharmaceutical preparations for the treatment of HIV/AIDS
aviarq

General Information

Serial Number78817912
Word MarkAVIARQ
Filing DateFriday, February 17, 2006
Status601 - ABANDONED - EXPRESS
Status DateWednesday, July 26, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pharmaceutical preparations for the treatment of HIV/AIDS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 24, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, July 26, 2006ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, July 26, 2006ABANDONMENT - EXPRESS MAILED
Wednesday, July 26, 2006ASSIGNED TO EXAMINER
Friday, April 7, 2006LETTER OF ABANDONMENT PROCESSED
Friday, April 7, 2006PAPER RECEIVED
Friday, February 24, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

aviarq disorders diseases preparations pharmaceutical treatment dysfunction sexual hemolytic namely obesity